Drug Database
Back to search

Poland· PL-100471938

Sitagliptin/Metformin hydrochloride Accord

A metformin and sitagliptin product containing sitagliptini hydrochloridum monohydricum + metformini hydrochloridum, registered in Poland by Accord Healthcare S.L.U.. The same ATC class is registered in 14 of our 19 countries.

ATC A10BD07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSitagliptin/Metformin hydrochloride A…ATCA10BD07REGISTER NO.PL-100471938PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sitagliptini hydrochloridum monohydricum + metformini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and sitagliptin is registered in 14 of 19 countries.

Countries holding a registration under ATC A10BD07 (metformin and sitagliptin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search metformin and sitagliptin products by name

Metformin and sitagliptin · ATC A10BD07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Sitagliptini hydrochloridum monohydricum + Metformini hydrochloridum
Manufacturer
Accord Healthcare S.L.U.
Country
Poland (PL)
ATC code
A10BD07
ATC class
Metformin and sitagliptin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and sitagliptin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and sitagliptin against other medicinesHow interaction checks work

Metformin and sitagliptin · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and sitagliptin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and sitagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Jamesi, Jansitin Duo
  • Belgium · Sitagliptin/Metformin Grindeks, Sitagliptin/Metformin Sandoz
  • Bulgaria · Jansitin Duo, Metlinka 50 Mg/1000 Mg
  • Cyprus · Diabremet, Jivolar
  • Czechia · Ansifora Duo, Asigefort
  • Germany · Metformax Combi, Metsunix
  • Denmark · Glerova, Sitagliptin/Metformin "sandoz"
  • Estonia · Asigefort, Diabremet
  • Spain · Disimet, Estequen
  • Finland · Brandasit, Sitagliptin/Metformin Glenmark
  • France · Sitagliptine/Chlorhydrate De Metformine Micro Labs, Sitagliptine/Chlorhydrate De Metformine Olpha
  • United Kingdom (Northern Ireland) · Sitagliptin / Metformin Hydrochloride Macleods, Sitagliptin / Metformin Hydrochloride Macleods Pharma Uk
  • Greece · Brandasit, Co-Fineria
  • Croatia · Condias Combi, Eprocliv
  • Hungary · Ansifora Duo, Asigefort
  • Ireland · Sitagliptin And Metformin Hydrochloride Ascend, Sitagliptin/Metformin Clonmel
  • Iceland · Aps, Efficib
  • Italy · Adiabin, Diesmit
  • Liechtenstein · Efficib, Janumet
  • Lithuania · Asigefort, Eprocliv
  • Latvia · Asigefort, Eprocliv
  • Malta · Combodiab Galenicum Health, Diabremet
  • Netherlands · Eprocliv, Fordiab
  • Norway · Efficib, Janumet
  • Portugal · Jivolar, Metformina + Sitagliptina Alter
  • Romania · Eprocliv, Jamesi
  • Sweden · Jivolar, Mifomet
  • Slovenia · Eprocliv, Jivolar
  • Slovakia · Ansifora Duo, Asigefort

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5ab3172-55bf-4d14-8cb9-0ebe42ef001f
GET /v1/drugs/c5ab3172-55bf-4d14-8cb9-0ebe42ef001f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg + 850 mg",
  "packaging": "Rp ¦ EU/1/22/1661/011 ¦ 146304\n30 tabl.\nRp ¦ EU/1/22/1661/012 ¦ 146305\n56 tabl.\nRp ¦ EU/1/22/1661/007 ¦ 146306\n196 tabl.\nRp ¦ EU/1/22/1661/016 ¦ 146307\n200 tabl.\nRp ¦ EU/1/22/1661/003 ¦ 146308\n30 tabl.\nRp ¦ EU/1/22/1661/005 ¦ 146309\n84 tabl.\nRp ¦ EU/1/22/1661/013 ¦ 146310\n84 tabl.\nRp ¦ EU/1/22/1661/015 ¦ 146311\n196 tabl.\nRp ¦ EU/1/22/1661/006 ¦ 146312\n168 tabl.\nRp ¦ EU/1/22/1661/002 ¦ 146313\n28 tabl.\nRp ¦ EU/1/22/1661/008 ¦ 146314\n200 tabl.\nRp ¦ EU/1/22/1661/014 ¦ 146315\n168 tabl.\nRp ¦ EU/1/22/1661/001 ¦ 146316\n10 tabl.\nRp ¦ EU/1/22/1661/009 ¦ 146317\n10 tabl.\nRp ¦ EU/1/22/1661/010 ¦ 146318\n28 tabl.\nRp ¦ EU/1/22/1661/004 ¦ 146319\n56 tabl.",
  "substance": "Sitagliptini hydrochloridum monohydricum 50 mg + Metformini hydrochloridum 850 mg",
  "common_name": "Sitagliptini hydrochloridum monohydricum + Metformini hydrochloridum",
  "pl_product_id": "100471938",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about metformin and sitagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console